Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Qlaira Regulatory Post Marketing Surveillance Study in Korea

Trial Profile

Qlaira Regulatory Post Marketing Surveillance Study in Korea

Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2019

At a glance

  • Drugs Estradiol valerate/dienogest (Primary)
  • Indications Menorrhagia; Pregnancy
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 15 May 2018 Status changed from active, no longer recruiting to completed.
    • 16 Apr 2018 Planned End Date changed from 6 Apr 2018 to 2 May 2018.
    • 10 Aug 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top